President Trump to lay out strategy for lowering drug prices

Before taking office, President Donald Trump railed against the pharmaceutical industry and accused it of “getting away with murder.”

Posted: May 11, 2018 1:38 PM

WASHINGTON (AP) — Before taking office, President Donald Trump railed against the pharmaceutical industry and accused it of “getting away with murder.”

The populist rhetoric appears to be giving way to a more nuanced strategy focused on making the pharmaceutical market more open and competitive, with the aim of lowering costs for consumers.

It’s an approach that could avoid a direct confrontation with the powerful pharmaceutical lobby, but it could also underwhelm Americans seeking relief from escalating prescription costs.

On Friday, Trump is scheduled to give his first speech on an overarching plan to lower drug prices. Administration officials previewing the speech Thursday touted it as the most comprehensive plan to tackle prescription drug costs that any president has ever proposed, but offered few specifics.

Officials said the plan would increase competition, create incentives for drugmakers to lower initial prices and slash federal rules that make it harder for private insurers to negotiate lower prices. The result would be lower pharmacy costs for patients — a key Trump campaign promise.

The plan will not include giving the federal Medicare program power to directly negotiate prices with drugmakers, they noted. Trump campaigned on the idea, which is vigorously opposed by the pharmaceutical industry.

Public outrage over drug costs has been growing for years, because Americans are being squeezed in a number of ways: New medicines for cancer and other life-threatening diseases often launch with prices exceeding $100,000 per year. Drugs for common ailments like diabetes and asthma routinely see price hikes around 10 percent annually. Meanwhile some companies have been buying up once-cheap older drugs and hiking prices by 1,000 percent or more.

Since entering the White House, Trump has backed away from reforms directly targeting drugmakers and staffed his administration with appointees who have deep ties to the industry, including his health secretary, Alex Azar, a former top executive at Eli Lilly.

Still, administration officials ratcheted up the rhetoric ahead of Trump’s speech. Azar promised bold action. FDA Commissioner Scott Gottlieb — another Trump appointee with industry connections — hinted at a plan to “dismantle” the convoluted system of discounts and rebates between drugmakers and health care middlemen.

On Thursday, administration officials also vowed to address foreign governments that rely on U.S. medicines but pay drastically lower prices due to government controls. The U.S. accounts for 70 percent of the world’s brand-name drug profits, according to a White House report released earlier this year.

Here are some of the drivers of U.S. prescription drug prices, proposals for reducing the costs and what’s at stake:

LACK OF REGULATION

Drugmakers generally can charge as much as the market will bear because the U.S. government doesn’t regulate medicine prices, unlike most other countries.

Medicare is the largest purchaser of prescription drugs in the nation, covering 60 million seniors and Americans with disabilities, but it is barred by law from directly negotiating lower prices with drugmakers. Democrats have long favored giving Medicare that power, but Republicans traditionally oppose the idea.

The powerful pharmaceutical lobby has repeatedly fended off proposals that could lower prices, such as Medicare negotiations or importing drugs from countries that regulate pricing.

With no direct government price regulation, the primary check on prices comes from buyers in bulk — such as insurance companies and pharmacy benefit managers, which handle prescription coverage for insurers, employers and other big clients.

But because there are so many players in the fragmented system, the discounts achieved in the U.S. are generally far more modest than those in other countries.

The result is that the U.S. spends more on medicines than any other nation. In 2015, the U.S. spent $1,162 per person on pharmaceuticals, according to the Organization for Economic Cooperation and Development. That compares with $756 for Canada and $497 for the United Kingdom, both of which have government measures to control drug prices.

LACK OF TRANSPARENCY

The U.S. system for pricing drugs is notoriously complex, so much that the “real” price for most medicines isn’t clear. Critics contend that this lack of transparency limits competition and drives prices higher.

Pharmaceutical companies often launch their drugs with high initial prices. But they argue list prices are merely a starting point for negotiations because they give substantial rebates and discounts to pharmacy benefit managers. Those price concessions are almost never disclosed and it’s unclear what portion actually flows back to consumers.

FDA Commissioner Scott Gottlieb and others say the lack of transparency in the current system creates perverse incentives in which drugmakers and other health care companies benefit from rising prices — at the expense of patients.

Trump officials have suggested requiring Medicare pharmacy benefit managers to share rebate payments with patients. Another proposal would do away with rebates altogether to encourage more upfront discounts in Medicare.

But the benefit managers and insurers say that they use rebates to lower health care premiums overall and that doing away with them would drive up costs.

PATENTS AND ANTI-COMPETITIVE TACTICS

Patents last longer in the U.S. than most countries, typically giving companies a dozen years of competition-free marketing after a drug launches. Most drugmakers increase their prices annually during this monopoly period, and until recently double-digit price hikes were the norm.

Drugmakers also have developed a number of techniques to block competitors from launching lower-cost generic drugs. Companies often tweak drug formulations to extend their patents. In other cases, companies directly pay would-be competitors to stay off the market in so-called “pay-to-delay” deals.

Gottlieb has promised a crackdown on some of these techniques used to “game the system.” He’s highlighted a practice in which drugmakers use tightly controlled distribution systems to prevent rival manufacturers from purchasing their drug. This effectively blocks the development of generic versions because generic drugmakers must test their products against the original medicine before they can win FDA approval.

PUBLIC PERCEPTION

A majority of Americans say bringing down prescription drug prices should be a “top priority” for Trump and Congress, according to recent polling by the Kaiser Family Foundation.

And experts who study drug pricing say it’s encouraging that the discussion around the issue has moved from outrage to sophisticated reforms. But some warn there is no guarantee that unraveling the current pricing-setting bureaucracy will lead to lower prices, because it all starts with drugmakers’ prices.

“Until we get closer to policy solutions that address the ability of drug manufacturers to set whatever price they want and increase prices year after year we may only be scratching the surface of this problem,” said Juliette Cubanski, a health care expert with the nonpartisan Kaiser Family Foundation.

Dan Mendelson, a health care consultant, said: “If they don’t address the cost that patients see at the pharmacy counter it’s not going to be seen as responsive.”

Terre Haute
Scattered Clouds
69° wxIcon
Hi: 83° Lo: 55°
Feels Like: 69°
Robinson
Overcast
67° wxIcon
Hi: 83° Lo: 52°
Feels Like: 67°
Indianapolis
Broken Clouds
67° wxIcon
Hi: 80° Lo: 60°
Feels Like: 67°
Rockville
Broken Clouds
62° wxIcon
Hi: 81° Lo: 54°
Feels Like: 62°
Casey
Overcast
62° wxIcon
Hi: 80° Lo: 53°
Feels Like: 62°
Brazil
Scattered Clouds
69° wxIcon
Hi: 81° Lo: 55°
Feels Like: 69°
Marshall
Scattered Clouds
69° wxIcon
Hi: 83° Lo: 53°
Feels Like: 69°
Rain showers expected overnight
WTHI Planner
WTHI Temps
WTHI Radar

Latest Video

Image

Sunday Evening Forecast

Image

Woman remembers national hero

Image

Terre Haute Symphony Orchestra Concert

Image

Athletes clean up Wabashiki

Image

High speed police chase ends in Vermillion county with gunfire

Image

Farms open for Fall season

Image

Annual Fall-out Ride

Image

'Cruisin' for Cruisers' car show

Image

Swing for a Cure

Image

Walk to End Alzheimer's

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Confirmed Cases: 288773

Reported Deaths: 8832
CountyConfirmedDeaths
Cook1430845203
DuPage17393560
Lake16794487
Will13917378
Kane13065326
St. Clair6574190
Winnebago5848149
Madison5666136
Champaign464520
McHenry4567118
Peoria345949
McLean326023
Rock Island297176
Kankakee273177
Unassigned2538244
Sangamon240145
Kendall199725
Tazewell174923
LaSalle170157
DeKalb156738
Macon150344
Coles145030
Williamson139045
Jackson125924
Clinton115320
Boone111323
Adams111210
Randolph93711
Effingham8653
Vermilion7454
Whiteside73820
Ogle6956
Monroe67315
Grundy6675
Henry6645
Morgan65523
Knox6483
Bureau63711
Jefferson60038
Marion5480
Macoupin5407
Christian53711
Franklin5303
Stephenson5176
Union51424
McDonough48015
Logan4611
Crawford4403
Woodford4206
Fayette4063
Cass39511
Jersey39015
Livingston3886
Shelby3854
Montgomery37113
Lee3681
Iroquois36419
Perry34715
Saline3344
Warren3302
Bond3225
Douglas3087
Wayne2785
Jo Daviess2592
Lawrence2542
Carroll2274
Greene22611
Cumberland2155
Hancock2153
Moultrie2143
Jasper2119
Washington2101
Richland2055
Fulton1740
Pulaski1741
Clark1722
White1670
Johnson1530
Clay1510
Wabash1513
Mason1451
Mercer1375
Piatt1370
Pike1271
Menard1251
De Witt1161
Edgar1138
Massac1092
Ford1045
Marshall1010
Alexander801
Scott780
Gallatin722
Hamilton681
Henderson660
Edwards630
Brown590
Calhoun590
Putnam570
Stark552
Schuyler490
Hardin390
Pope291
Out of IL30

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Confirmed Cases: 116549

Reported Deaths: 3577
CountyConfirmedDeaths
Marion21322766
Lake10566323
Elkhart6623111
St. Joseph6488109
Allen6244203
Hamilton4893109
Vanderburgh365231
Hendricks2741123
Monroe259836
Tippecanoe248313
Johnson2328124
Clark222757
Porter215447
Delaware196062
Cass19509
Vigo183527
Madison167075
LaPorte144440
Floyd137063
Warrick133039
Howard131363
Kosciusko121817
Bartholomew117057
Marshall100724
Boone98146
Dubois97919
Hancock93043
Grant92534
Noble91532
Henry80326
Wayne76114
Jackson7589
Morgan72438
Shelby67429
Daviess67228
Dearborn66428
LaGrange63811
Clinton60214
Harrison58224
Putnam57912
Gibson5225
Knox5179
Lawrence51229
Montgomery51121
White48614
DeKalb48311
Decatur45839
Miami4363
Greene42635
Fayette42213
Jasper3962
Steuben3857
Scott37711
Sullivan33712
Posey3350
Jennings31412
Franklin30925
Clay3015
Ripley2988
Orange28824
Whitley2766
Carroll27513
Wabash2688
Adams2663
Washington2661
Starke2647
Wells2634
Jefferson2483
Spencer2463
Fulton2412
Huntington2363
Tipton22722
Perry21913
Randolph2167
Jay1850
Newton17311
Owen1691
Martin1660
Rush1554
Pike1511
Vermillion1300
Fountain1272
Blackford1193
Pulaski1131
Crawford1070
Brown1043
Parke1002
Benton870
Union790
Ohio787
Switzerland690
Warren401
Unassigned0226